
Neal Devaraj: Blurring the Lines Between Chemistry and Biology
07/28/23 • 47 min
Neal Devaraj is a Professor and Chair at the University of California San Diego. In this episode, Neal talks about the innovations he has pioneered that are advancing the field of bioorthogonal chemistry. We discuss Neal’s work synthesizing completely artificial cells, designing new tools for labeling RNA, and his contribution to “click chemistry” by developing tetrazine ligation for use in live-cell imaging.
Neal Devaraj is a Professor and Chair at the University of California San Diego. In this episode, Neal talks about the innovations he has pioneered that are advancing the field of bioorthogonal chemistry. We discuss Neal’s work synthesizing completely artificial cells, designing new tools for labeling RNA, and his contribution to “click chemistry” by developing tetrazine ligation for use in live-cell imaging.
Previous Episode

Amy Ripka: Mitochondrial Dysfunction and New Ideas in Drug Discovery
Amy Ripka is the founder and CEO of Lucy Therapeutics. This back of the napkin conversation focuses on the importance of having the freedom to explore and generate new ideas. The approach that Amy advocates in this podcast has led her to pivotal new discoveries, including potential new therapeutics for Parkinson’s disease and Rett syndrome.
Lucy therapeutics: https://www.lucytherapeutics.com/
Paper - Playing Mozart to Chemical Reactions: https://jabde.com/2022/04/08/echocatalysis-playing-mozart-to-chemical-reactions/
Next Episode

Michelle Arkin: Stabilizing Protein-Protein Interactions for Therapeutic Applications
Michelle Arkin is a Professor of Pharmaceutical Chemistry at the University of California, San Francisco (UCSF). She is also a director of the Small Molecule Discovery Center (SMDC), a chemical biology and drug discovery center at UCSF. Michelle has extensive experience in the field of drug discovery and is working on new and complex challenges to demonstrate 'druggability' of new target classes. Michelle is also the cofounder of Ambagon Therapeutics who are building on the concepts of modulating protein-protein interactions to find new drugs that address unmet needs in cancer, metabolic disorders, neurodegeneration and infectious diseases.
Small Molecule Discovery Center: https://pharm.ucsf.edu/smdc
Arkin Lab: https://pharm.ucsf.edu/arkin
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/back-of-the-napkin-inspiring-stories-from-biotech-pioneers-491150/neal-devaraj-blurring-the-lines-between-chemistry-and-biology-65230131"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to neal devaraj: blurring the lines between chemistry and biology on goodpods" style="width: 225px" /> </a>
Copy